Su1279 Metformin lowers the risk of gastric cancer in patients with gastric adenomas and type 2 diabetes compared to alternate glucose lowering agents

Authors

• Chimezirim Ezeano, Advocate Health - MidwestFollow
• Chetan Mittal
• Francis O. Edeani

Recommended Citation

Ezeano C, Mittal C, Edeani FO. Su1279 Metformin lowers the risk of gastric cancer in patients with gastric adenomas and type 2 diabetes compared to alternate glucose lowering agents. Gastroenterology. 2026;170(6):S-2605. doi:10.1016/S0016-5085(26)06167-6

Type

Abstract